AstraZeneca's Farxiga ad, which comes across as very serious with the use of a target and slightly menacing music as you pull out to reveal its shape, is a “call to action,” Walters said, ...

AstraZeneca has watched superstar SGLT2 diabetes med Farxiga nail trial after trial in highly coveted kidney and heart failure indications, with the FDA expediting reviews to back them up.

AstraZeneca AZN stock has risen 8.6% in the past month, ... AstraZeneca expects Farxiga and Lynparza to be included in the ...

AstraZeneca's blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of heart failure, according to study data released ...

AstraZeneca's Farxiga reduced the risk of hospitalisation and death in people with all types of heart failure in the DELIVER trial, which could dramatically increase the population of patients ...

British drugmaker AstraZeneca Plc said on Tuesday that its diabetes drug Farxiga was successful in reducing the risk of death by heart attack or the worsening of a type of heart failure in a late ...

AstraZeneca achieved record revenue growth of 18% in 2024, driven by key products like Farxiga and Tagrisso, and numerous regulatory approvals. The company’s diversified portfolio spans oncology ...

AstraZeneca AZN announced that the FDA has issued a complete response letter ("CRL") to its supplemental new drug application (sNDA) for SGLT2 inhibitor, Farxiga (dapagliflozin).

AstraZeneca PLC said Monday that a Phase 3 trial to assess the potential of its Farxiga diabetes drug to treat patients with Covid-19 at risk of developing serious complications didn't achieve ...